CCL3 and neuropathy: MIP-1α also showed a decrease (p < 0.0001) in its expression in animals treated with amantadine, with the reduction being more pronounced at the highest dose tested (50 mg/kg), suggesting a role for the macrophage inflammatory protein in the mechanism of chemotherapy neuropathy and the anti-inflammatory mechanism of amantadine.